- Home
- SIF vs PIRS Comparison
SIF vs PIRS Comparison
Compare SIF & PIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIF
- PIRS
- Stock Information
- Founded
- SIF 1913
- PIRS 2001
- Country
- SIF United States
- PIRS United States
- Employees
- SIF N/A
- PIRS N/A
- Industry
- SIF Office Equipment/Supplies/Services
- PIRS Biotechnology: Pharmaceutical Preparations
- Sector
- SIF Industrials
- PIRS Health Care
- Exchange
- SIF Nasdaq
- PIRS Nasdaq
- Market Cap
- SIF 21.7M
- PIRS 22.4M
- IPO Year
- SIF N/A
- PIRS N/A
- Fundamental
- Price
- SIF $3.88
- PIRS $15.93
- Analyst Decision
- SIF
- PIRS
- Analyst Count
- SIF 0
- PIRS 0
- Target Price
- SIF N/A
- PIRS N/A
- AVG Volume (30 Days)
- SIF 18.7K
- PIRS 37.6K
- Earning Date
- SIF 12-27-2024
- PIRS 11-13-2024
- Dividend Yield
- SIF N/A
- PIRS N/A
- EPS Growth
- SIF N/A
- PIRS N/A
- EPS
- SIF N/A
- PIRS N/A
- Revenue
- SIF $101,482,000.00
- PIRS $1,352,000.00
- Revenue This Year
- SIF N/A
- PIRS N/A
- Revenue Next Year
- SIF N/A
- PIRS N/A
- P/E Ratio
- SIF N/A
- PIRS N/A
- Revenue Growth
- SIF 25.24
- PIRS N/A
- 52 Week Low
- SIF $2.87
- PIRS $6.20
- 52 Week High
- SIF $5.96
- PIRS $22.32
- Technical
- Relative Strength Index (RSI)
- SIF 53.59
- PIRS 43.29
- Support Level
- SIF $3.50
- PIRS $15.15
- Resistance Level
- SIF $3.68
- PIRS $16.97
- Average True Range (ATR)
- SIF 0.18
- PIRS 0.72
- MACD
- SIF 0.05
- PIRS -0.08
- Stochastic Oscillator
- SIF 62.16
- PIRS 30.75
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About PIRS Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.